Drug maker Mallinckrodt, on the hook for more than $1 billion in opioid settlement payments, plans to file for bankruptcy for a second time. The move imperils the $1.7 billion opioid settlement struck last year.
The target “blatantly advertised” chemicals and targeted cartel clients with claims of “Mexico hot sale” and “100% stealth shipping,” federal officials say.